Logo image of OCG.CA

OUTCROP SILVER & GOLD CORP (OCG.CA) Stock Fundamental Analysis

TSX-V:OCG - TSX Venture Exchange - CA69002Q1054 - Common Stock - Currency: CAD

0.23  -0.01 (-4.17%)

Fundamental Rating

2

Overall OCG gets a fundamental rating of 2 out of 10. We evaluated OCG against 808 industry peers in the Metals & Mining industry. OCG has a great financial health rating, but its profitability evaluates not so good. OCG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OCG had negative earnings in the past year.
In the past year OCG has reported a negative cash flow from operations.
In the past 5 years OCG always reported negative net income.
OCG had a negative operating cash flow in each of the past 5 years.
OCG.CA Yearly Net Income VS EBIT VS OCF VS FCFOCG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -72.02%, OCG is not doing good in the industry: 70.79% of the companies in the same industry are doing better.
With a Return On Equity value of -74.83%, OCG is not doing good in the industry: 61.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -72.02%
ROE -74.83%
ROIC N/A
ROA(3y)-121.69%
ROA(5y)-109.47%
ROE(3y)-136.06%
ROE(5y)-120.66%
ROIC(3y)N/A
ROIC(5y)N/A
OCG.CA Yearly ROA, ROE, ROICOCG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OCG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCG.CA Yearly Profit, Operating, Gross MarginsOCG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for OCG has been increased compared to 1 year ago.
OCG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OCG has been reduced compared to a year ago.
OCG.CA Yearly Shares OutstandingOCG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
OCG.CA Yearly Total Debt VS Total AssetsOCG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

An Altman-Z score of 67.90 indicates that OCG is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 67.90, OCG belongs to the best of the industry, outperforming 91.34% of the companies in the same industry.
OCG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 67.9
ROIC/WACCN/A
WACCN/A
OCG.CA Yearly LT Debt VS Equity VS FCFOCG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 6.24 indicates that OCG has no problem at all paying its short term obligations.
OCG has a better Current ratio (6.24) than 79.70% of its industry peers.
A Quick Ratio of 6.24 indicates that OCG has no problem at all paying its short term obligations.
OCG has a Quick ratio of 6.24. This is in the better half of the industry: OCG outperforms 79.70% of its industry peers.
Industry RankSector Rank
Current Ratio 6.24
Quick Ratio 6.24
OCG.CA Yearly Current Assets VS Current LiabilitesOCG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for OCG have decreased strongly by -11.45% in the last year.
EPS 1Y (TTM)-11.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OCG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCG.CA Price Earnings VS Forward Price EarningsOCG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCG.CA Per share dataOCG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OCG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTCROP SILVER & GOLD CORP

TSX-V:OCG (6/16/2025, 7:00:00 PM)

0.23

-0.01 (-4.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-17 2025-04-17
Earnings (Next)07-21 2025-07-21
Inst Owners0.52%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap86.52M
Analysts84.44
Price Target0.51 (121.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.92
P/tB 4.92
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.02%
ROE -74.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-121.69%
ROA(5y)-109.47%
ROE(3y)-136.06%
ROE(5y)-120.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 796.97%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.24
Quick Ratio 6.24
Altman-Z 67.9
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)320.44%
Cap/Depr(5y)603.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.02%
OCF growth 3YN/A
OCF growth 5YN/A